Yeytuo

Yeytuo (lenacapavir) is a long-acting antiretroviral medication used for HIV treatment and prevention. It belongs to the capsid inhibitor class and is administered via subcutaneous injection. This overview covers its uses, effects, and safety considerations for general information.

Lenacapavir is used to treat HIV-1 infection in adults and adolescents as part of combination therapy. It works by blocking the HIV capsid protein, disrupting the virus’s ability to replicate. The medication is also approved for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection in high-risk individuals. Healthcare providers may prescribe it when other treatments are not suitable.

Lenacapavir is designed for long-term use, providing sustained drug levels in the body to maintain viral suppression. Users may experience injection-site reactions, such as redness or swelling, which are typically mild and temporary. Some individuals report fatigue or headache, though these effects vary by person.

Store lenacapavir in a refrigerator until use, but it can be kept at room temperature for a limited time. Avoid exposing the medication to extreme heat or direct sunlight. Always check the solution for particles or discoloration before use. Discard any unused portion after the prescribed duration.

Lenacapavir may interact with other medications that affect liver enzymes, such as CYP3A inhibitors or inducers, which can alter its effectiveness. Avoid alcohol and herbal supplements unless approved by a healthcare provider. Consult a doctor before combining it with other drugs to prevent potential interactions.